09:32 AM EST, 03/03/2025 (MT Newswires) -- Aclarion ( ACON ) shares rallied sharply early Monday after the healthcare technology company said it has established a commercial agreement with Scripps Health that will add its Nociscan technology platform to treat lower back pain to Scripps facilities in San Diego.

The agreement is expected to optimize Scripps' clinical treatment by providing Aclarion's ( ACON ) magnetic resonance spectroscopy signal processing and allowing physicians to non-invasively distinguish between lumbar discs causing pain and non-painful discs, the companies said.

Financial terms were not disclosed.

Aclarion ( ACON ) shares climbed by more than 125% in early trading.